English
 
Help Privacy Policy Disclaimer
  Advanced SearchBrowse

Item

ITEM ACTIONSEXPORT

Released

Journal Article

Neuroprotection by rAAV-mediated gene transfer of bone morphogenic protein 7

MPS-Authors
/persons/resource/persons94354

Heinonen,  Ann-Marie
Department of Molecular Neurobiology, Max Planck Institute for Medical Research, Max Planck Society;

/persons/resource/persons92690

Dogbevia,  Godwin
Department of Molecular Neurobiology, Max Planck Institute for Medical Research, Max Planck Society;

/persons/resource/persons95439

Sprengel,  Rolf
Department of Molecular Neurobiology, Max Planck Institute for Medical Research, Max Planck Society;

Fulltext (restricted access)
There are currently no full texts shared for your IP range.
Fulltext (public)
There are no public fulltexts stored in PuRe
Supplementary Material (public)
There is no public supplementary material available
Citation

Heinonen, A.-M., Rahman, M., Dogbevia, G., Jakobi, H., Wölfl, S., Sprengel, R., et al. (2014). Neuroprotection by rAAV-mediated gene transfer of bone morphogenic protein 7. BMC Neuroscience, 15(1), 38-49. doi:10.1186/1471-2202-15-38.


Cite as: https://hdl.handle.net/11858/00-001M-0000-0019-8F88-8
Abstract
Bone morphogenic proteins (BMPs) promote the survival of neurons, suggesting a therapeutic application of BMPs in the treatment of acute and chronic neurodegenerative disorders. However, the application of recombinant BMPs in vivo is limited by their short half-life. To provide a continuous supply for functionally active BMPs, we expressed BMP7, BMP2 and the BMP inhibitor Noggin under the control of rAAV vectors in vivo. For visual control of rAAV-mediated BMP (v-BMP) expression we fused the secreted morphogenic polypeptides and the fluorescent reporter protein Venus via the ‘ribosomal skip’ promoting 2A peptide-bridge.